Blueprint Medicines Corp (FRA:2L9)
€ 78 -1.82 (-2.28%) Market Cap: 5.05 Bil Enterprise Value: 4.79 Bil PE Ratio: 0 PB Ratio: 17.26 GF Score: 73/100

Blueprint Medicines Corp (FRA:2L9) Transcripts

  • 1